Physician profile

Ted O Mason

General Practice (Dentist) · Wichita, KS

NPI 1891883278

$3,283.69

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$59.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
A-Dec, INC. $1,580.00 2020
Dentsply Sirona INC $1,024.80 2022-2024 Cavitron, Astra Tech Implant System
Align Technology, INC. $264.92 2020-2021
Dentsply LLC $99.00 2021
Henry Schein, INC. $73.46 2019
Patterson Companies, INC. $71.31 2019-2024
Ultradent Products INC $66.22 2022-2024
Hu-Friedy Mfg. Co., LLC $39.51 2020
Peter Brasseler Holdings, LLC $24.70 2019
Dentsply Ih INC. $20.80 2019
Straumann USA LLC $18.97 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ted O Mason

$3,283.69

in general payments reported 2019-2025

Years
2019-2024
Top company
A-Dec, INC.

https://glasscript.com/doctor/40334/ted-o-mason

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.